BR0116919A - Processo para purificação de ácido de varfarina, sais de metais alcalinos de varfarina e clatratos correspondentes - Google Patents
Processo para purificação de ácido de varfarina, sais de metais alcalinos de varfarina e clatratos correspondentesInfo
- Publication number
- BR0116919A BR0116919A BR0116919-0A BR0116919A BR0116919A BR 0116919 A BR0116919 A BR 0116919A BR 0116919 A BR0116919 A BR 0116919A BR 0116919 A BR0116919 A BR 0116919A
- Authority
- BR
- Brazil
- Prior art keywords
- acid
- warfarin
- purifying
- varpharine
- solution
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
- C07D311/44—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3
- C07D311/46—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3 unsubstituted in the carbocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"PROCESSO PARA PURIFICAçãO DE áCIDO DE VARFARINA, SAIS DE METAIS ALCALINOS DE VARFARINA E CLATRATOS CORRESPONDENTES". A invenção refere-se a um procedimento aperfeiçoado para a purificação de ácido de varfarina. Sais de varfarina sódio, potássio e lítio e os clatratos correspondentes são preparados em alta, pureza de grau de farmacopéia e bons rendimentos a partir do ácido de varfarina puro e as respectivas bases de sais de metais em meio adequado. O processo para preparar ácido de varfarina puro a partir do ácido de varfarina bruto inicia suspendendo o ácido bruto em um solvente imiscível em água, extraindo o ácido em uma solução aquosa de base diluída, separando a fase aquosa resultante e diluindo-a com um álcool de alquila inferior. A solução aquosa é filtrada antes de ser diluída com o álcool de alquila inferior. A solução é acidificada a um pH de aproximadamente 2 a 5 usando um ácido adequado, tal como ácido clorídrico, sulfúrico ou fosfórico. A suspensão resultante é agitada a uma temperatura de aproximadamente 20<198>C a cerca de 60<198>C, esfriando a suspensão abaixo da temperatura ambiente, filtrando o ácido de varfarina puro e secando.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27173701P | 2001-02-28 | 2001-02-28 | |
PCT/US2001/050438 WO2002070503A1 (en) | 2001-02-28 | 2001-12-28 | Process for purification of warfarin acid, warfarin alkali metal salts and corresponding clathrates |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0116919A true BR0116919A (pt) | 2004-10-13 |
Family
ID=23036855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0116919-0A BR0116919A (pt) | 2001-02-28 | 2001-12-28 | Processo para purificação de ácido de varfarina, sais de metais alcalinos de varfarina e clatratos correspondentes |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1363893A1 (pt) |
CN (1) | CN1505620A (pt) |
BR (1) | BR0116919A (pt) |
CA (1) | CA2439488A1 (pt) |
IL (1) | IL157555A0 (pt) |
MX (1) | MXPA03007769A (pt) |
RU (1) | RU2003129000A (pt) |
WO (1) | WO2002070503A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN2012CN10302A (pt) * | 2010-05-20 | 2015-06-12 | Apotex Pharmachem Inc | |
WO2011145007A1 (en) | 2010-05-20 | 2011-11-24 | Alembic Pharmaceuticals Limited | A process for the preparation of amorphous warfarin sodium |
CN109369450B (zh) * | 2018-10-31 | 2021-07-27 | 江苏省农用激素工程技术研究中心有限公司 | 三甲苯草酮的精制方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2777859A (en) * | 1953-02-05 | 1957-01-15 | Wisconsin Alumni Res Found | Warfarin-alkali metal derivatives and processes of preparing the same |
US2765321A (en) * | 1955-05-27 | 1956-10-02 | Wisconsin Alumni Res Found | Process of making crystalline warfarin sodium |
FR1397213A (fr) * | 1963-05-14 | 1965-04-30 | Frosst & Co Charles E | Nouveau procédé de préparation de la warfarine-sodium |
US4113744A (en) * | 1974-08-13 | 1978-09-12 | Nasri W. Badran | Microcrystalline 3-(alpha-acetonylbenzyl)-4-hydroxycoumarin (warfarin) and methods of making |
US4826689A (en) * | 1984-05-21 | 1989-05-02 | University Of Rochester | Method for making uniformly sized particles from water-insoluble organic compounds |
US5696274A (en) * | 1995-12-28 | 1997-12-09 | Hoechst Celanese Corporation | Syntheses based on 2-hydroxyacetophenone |
-
2001
- 2001-12-28 WO PCT/US2001/050438 patent/WO2002070503A1/en not_active Application Discontinuation
- 2001-12-28 RU RU2003129000/04A patent/RU2003129000A/ru unknown
- 2001-12-28 CN CNA018231594A patent/CN1505620A/zh active Pending
- 2001-12-28 MX MXPA03007769A patent/MXPA03007769A/es unknown
- 2001-12-28 CA CA002439488A patent/CA2439488A1/en not_active Abandoned
- 2001-12-28 EP EP01985145A patent/EP1363893A1/en not_active Withdrawn
- 2001-12-28 IL IL15755501A patent/IL157555A0/xx unknown
- 2001-12-28 BR BR0116919-0A patent/BR0116919A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MXPA03007769A (es) | 2005-07-01 |
CN1505620A (zh) | 2004-06-16 |
IL157555A0 (en) | 2004-03-28 |
WO2002070503A1 (en) | 2002-09-12 |
RU2003129000A (ru) | 2005-05-10 |
EP1363893A1 (en) | 2003-11-26 |
CA2439488A1 (en) | 2002-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10464888B2 (en) | Process for the preparation of isosulfan blue | |
CN105541819A (zh) | 一种依匹唑派的制备方法及其中间体和中间体的制备方法 | |
ES2187483T3 (es) | Procedimiento para la preparacion de acido a-lipoico esento de disolvente. | |
BR0116919A (pt) | Processo para purificação de ácido de varfarina, sais de metais alcalinos de varfarina e clatratos correspondentes | |
IT1319196B1 (it) | Sintesi dell'acido r(+)alfa-lipoico. | |
US6512005B2 (en) | Process for synthesis of pure warfarin acid, warfarin alkali metal salts and corresponding clathrates | |
JPH1180149A (ja) | (±)−クロマンカルボン酸の光学分割法 | |
KR100357660B1 (ko) | 장애 설폰아미드를 알킬화시키는 방법 | |
CN101012192A (zh) | 一种佐芬普利钙的制备方法 | |
CN109096186B (zh) | 一种2-芳磺酰基喹啉衍生物的合成方法 | |
SK287975B6 (sk) | Process for preparation of (R)-(-)-2-hydroxy-2-(2- chlorophenyl)acetic acid and its salt | |
WO2015012271A1 (ja) | 複素環化合物の製造方法 | |
CN103319385B (zh) | 一种2-甲氧基-4-氨基-5-乙砜基苯甲酸的合成方法 | |
PL91814B1 (pt) | ||
CN103570618A (zh) | 一种孟鲁司特钠盐的制备方法 | |
ITMI980284A1 (it) | Processo per la preparazione dell'acido 3-[4-(1-h-imidazol-1-il- metil]-2 propenoico ed i suoi sali | |
CA2378337A1 (en) | Method for the preparation of 2-methoxy-4-(n-t-butylamino-carbonyl)-benzenesulfonyl chloride | |
CN109280049B (zh) | 一种医药化合物阿伐那非的合成方法 | |
JP4359669B2 (ja) | ジヒドロキシジフェニルスルホンの製造方法 | |
CN103304453A (zh) | 两步法合成2-甲氧基-4-氨基-5-乙砜基苯甲酸 | |
JPH10158235A (ja) | 4,4’−ジヒドロキシジフェニルスルホンモノエーテル誘導体の精製法 | |
JP2002167381A (ja) | (±)−6−ヒドロキシ−2,5,7,8−テトラメチルクロマン−2−カルボン酸の光学分割法 | |
CN105418465A (zh) | P9e6so的合成方法 | |
CN109867664A (zh) | 核苷类似物拉米夫定的制备方法 | |
JPS6140249A (ja) | 3−(n−置換アミノ)−4−(2−メトキシフエノキシ)安息香酸誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: TARO PHARMACEUTICAL INDUSTRIES LTD. (IL) Free format text: TRANSFERIDO DE: TARO PHARMACEUTICALS U.S.A., INC. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 4A, 5A E 6A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 1964 DE 26/08/2008 E CONSIDERANDO A AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS. |